VSIG2 and colorectal carcinoma: Further, VSIG2 was identified as a significantly dysregulated differential protein in colorectal cancer (CRC) through iTRAQ labeling proteomics and TMT labeling phospho-proteomics analysis of CRC tissues and adjacent normal tissues [33].